---
title: Boston Bioprocess vs KBI Biopharma, Inc.
slug_a: bostonbioprocess
slug_b: kbibiopharma
site: cdmo
review_signal_gate: closed
canonical_path: /compare/bostonbioprocess/kbibiopharma
---

# Boston Bioprocess vs KBI Biopharma, Inc.

Side-by-side profile data from each company listing on this directory.

## Boston Bioprocess

- Profile: [/companies/bostonbioprocess](/companies/bostonbioprocess)

Boston Bioprocess — Boston Bioprocess offers contract development and scale-up services for biotech innovators, including fermentation optimization, downstream process development, and tech transfer to CMOs. It also sells software for batch execution and process analysis.

Services: 6. Modalities: 1. Indications: 0. Locations: 2. Certifications: 0. The strongest documented coverage currently appears in services (6).

### Services

- Upstream Processing
- Downstream Processing
- Microbial Fermentation
- Process Development
- Technology Transfer
- CMC Regulatory Submission Support

### Modalities

- Biologics (Other)

### Development capabilities

- Data not yet provided.

### Manufacturing capabilities

- Drug Substance (DS)
- Max bioreactor: Mid-scale clinical (≤2,000 L)
- Expression: Microbial

## KBI Biopharma, Inc.

- Profile: [/companies/kbibiopharma](/companies/kbibiopharma)

KBI Biopharma, Inc. — Global CDMO offering cell line development, process and analytical development, formulation development, and clinical and commercial manufacturing for mammalian and microbial biologics.

Services: 13. Modalities: 2. Indications: 1. Locations: 11. Certifications: 1. The strongest documented coverage currently appears in services (13).

### Services

- Biologics Development & Manufacturing
- Monoclonal Antibody (mAb) Manufacturing
- Recombinant Protein Manufacturing
- Cell-Line Development
- Upstream Processing
- Downstream Processing
- Microbial Fermentation
- Process Development
- Formulation Development
- CMC Analytical Development
- Quality Control Testing
- Stability Testing & Storage
- CMC Regulatory Submission Support

### Modalities

- Biologics (Monoclonal Antibodies)
- Biologics (Other)

### Development capabilities

- Analytical method development
- Formulation development
- ICH stability testing
- Cell line development

### Manufacturing capabilities

- Drug Substance (DS)
- Drug Product (DP)
- Expression: Mammalian
- Expression: Microbial
- Single-Use / Disposable